An assessment of the screening performance of a single-item measure of depression from the Edmonton Symptom Assessment Scale among chronically ill hospitalized patients.

Journal of Pain and Symptom Management
Steven Z PantilatC Seth Landefeld

Abstract

Few studies have examined the validity of using a single item from the Edmonton Symptom Assessment Scale (ESAS) for screening for depression. To examine the screening performance of the single-item depression question from the ESAS in chronically ill hospitalized patients. A total of 162 chronically ill inpatients aged 65 and older completed a survey after admission that included the well-validated, 15-item Geriatric Depression Scale (GDS-15) and four single-item screening questions for depression based on the ESAS question, using two different time frames ("now" and "in the past 24 hours") and two response categories (a 0-10 numeric rating scale [NRS] and a categorical scale: none, mild, moderate, and severe). The GDS-15 categorized 20% (n = 33) of participants as possibly being depressed with a score ≥ 6. The NRS for depression "now" achieved the highest level of sensitivity at a cutoff ≥ 1 (68.8%), and an acceptable level of specificity was obtained at a cutoff of ≥ 5 (82.2%). For depression "in the past 24 hours," a cutoff of ≥ 1 achieved a sensitivity of 68.8% and a cutoff of ≥ 7 a specificity of 80.3%. For the categorical scale, a cutoff of "none" provided the best level of sensitivity for depression "now" (65.6%) and "in...Continue Reading

References

Jun 15, 1995·Annals of Internal Medicine·C D MulrowC Kerber
May 17, 2000·Cancer·V T ChangM Feuerman
May 22, 2002·Annals of Internal Medicine·Michael P PignoneKathleen N Lohr
Apr 5, 2003·The American Psychologist·James F Hemphill
Aug 10, 2004·Social Psychiatry and Psychiatric Epidemiology·Sasi A WillmottPeter W Jones
Apr 25, 2006·Journal of Palliative Medicine·Ernesto VignaroliEduardo Bruera
Oct 28, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sharon WatanabeAsifa Mawani
Apr 1, 2009·The American Journal of Medicine·Nancy M AlbertJames B Young
Apr 25, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Tanya E DavisonDavid Mellor
Dec 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian J NelsonAndrew J Roth
Dec 15, 2010·Archives of Internal Medicine·Steven Z PantilatC Seth Landefeld

❮ Previous
Next ❯

Citations

May 1, 2013·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·Marian WilsonCelestina Barbosa-Leiker
Oct 24, 2015·Journal of Clinical Psychology in Medical Settings·Cathaleene MaciasTrishan Panch
May 1, 2013·Journal of Pain and Symptom Management·Jung Hye KwonEduardo Bruera
Jul 22, 2016·Revista da Associação Médica Brasileira·Mariana da Silva Roldi, Rachel Duarte Moritz
Nov 22, 2019·The Australian and New Zealand Journal of Psychiatry·Joshua D RosenblatAndre F Carvalho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.